Growth of Swine Fever Vaccine Market

The global Swine Fever Vaccine Market is estimated to be valued at US$ 2885.25 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Swine fever vaccines help prevent swine fever, a contagious viral disease affecting pigs. The vaccines provide protection, allow sustainable pig farming and ensure food security.

Market key trends:

One of the key trends in the swine fever vaccine market is the development of novel vaccines. Researchers are developing new generation vaccines based on modern vaccine platforms such as DNA vaccines and subunit vaccines. These novel vaccines induce strong immune response, require less number of doses for protection and have potential for differentiation of infected animals from vaccinated animals. Some of the key players involved in development of novel swine fever vaccines are Merck & Co., Inc., Ceva, and Indian Immunologicals Ltd.

Segment Analysis:

The global swine fever vaccine market is categorized based on type and region. Based on type, the market is segmented into live vaccines and inactivated vaccines. The live vaccines segment dominated the market in 2020 owing to enhanced porcine immunity and high survivability rate among pigs offered by this type of vaccine.

Key Takeaways:

The Global Swine Fever Vaccine Market Size is expected to grow at a CAGR of 5.9% over the forecast period from 2023 to 2030. The market was valued at US$ 2,885.25 million in 2023. Rapid industrialization of pig farming practices is expected to drive the market during the forecast period.

Regional analysis:

Asia Pacific dominated the global market in 2020 and is projected to exhibit the highest growth over the forecast period. This is attributed to rising pig population and frequent outbreaks of swine fever in major pork producing countries including China and India.

Key players:

Key players operating in the swine fever vaccine market are Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., Komipharm, and EC21 Inc. Merck & Co., Inc. (Merck Animal Health) currently dominates the global market.

Comments

Rails to Resilience: Strategies Driving Growth in the Railway Coatings Market

Railway Coatings Market Railway coatings play a critical role in protecting rail infrastructure against corrosion, abrasion, and weathering, thereby extending the lifespan of railway assets and enhancing operational efficiency. The Railway Coatings Market encompasses a diverse range of coatings specifically formulated to meet the unique requirements of rail applications, including coatings for rolling stock, track components, bridges, and stations. As the global rail industry continues to expand and modernize, the demand for high-performance coatings that offer durability, safety, and environmental sustainability is on the rise. The railway coatings market was valued at US$ 2,334.2 Mn in 2024 , and is expected to exhibit a CAGR of 5.2% , in terms of revenue, over the forecast period 2024-2031 to reach US$ 3,497.6 Mn by 2031 . Key Takeaways: The Railway Coatings Market is witnessing steady growth, driven by various factors such as infrastructure development ...

The Global Antifoaming Agent Market is poised to Exhibit Strong Growth

Antifoaming Agent Market The antifoaming agent market is fast gaining traction due to increasing industrial usage of chemicals, especially in numerous end-use sectors like pharmaceuticals, pulp & paper, paints & coatings, oil & gas, and food & beverages. Antifoaming agents are chemicals that reduce or suppress the formation of foam in industrial processes. They are widely used as additives to prevent foaming issues in various industrial applications. Commonly used antifoaming agents include silicone-based, oil-based, and water-based defoamers. These agents find usage in processes involving agitation to prevent excessive foaming that can negatively impact manufacturing operations and product quality. The Global Antifoaming Agent Market is estimated to be valued at US$ 6.08 Bn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global Antifoaming Agent market are BASF, Evonik Industries, Air P...

Sustainable Aviation Fuel Market is Set to Witness Significant Growth Due to Stringent Emission Norms

Sustainable Aviation Fuel Market Sustainable aviation fuel, also known as biofuel, refers to jet fuel produced from sustainable feedstocks such as grease, vegetable oils and animal fats. It is mandated to reduce the environmental impact of aviation, with a life cycle carbon footprint up to 80% lower than conventional jet fuel. Governments across regions are adopting policies and targets to promote sustainable aviation fuel uptake among airlines. For instance, the EU aims to reach 2 million tons of sustainable fuel per year by 2030. The global sustainable aviation fuel market is estimated to be valued at US$ 2.37 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the sustainable aviation fuel are Eisai Co., Ltd., Novartis AG, AbbVie Inc. (Allergan Plc.), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, F. Hoffmann La Roche Ltd., Daiichi Sankyo Company, Limited, Johnson & Johnson Services,...

Dive into insights

Search This Blog